University of California San Francisco
Give to UCSF
Medication abortion can be delivered safely and effectively through telemedicine, according to new research that comes as the U.S. Supreme Court is about to hear a case that could severely restrict access to one of the two pills that are used to induce abortions.
Cancer immunotherapy is hindered by the fact that engineered immune cells often get worn out and depleted before they've killed a tumor. A UCSF team has identified mutations that give cancerous lymphoma T-cells their superpower and transfer those genes into engineered, therapeutic immune cells.
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on vaccines, masking, and other ways to protect yourself.
Cell biologist and engineer Matthew Kutys, PhD, and his team harness organoids – living tissues derived from patient tumors – to study how cancer spreads.
UCSF’s industry archives expose the marketing tactics that fueled the opioid epidemic.
What a tiny grassroots program in the Tenderloin is teaching doctors about healing through human connection.
Eric J. Small, MD, UCSF professor of Medicine and Urology Credit: UCSFThe American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term
It is clear the next year will be a pivotal one for UCSF’s place in the growth and application of artificial intelligence in health care. Chancellor Sam Hawgood, MBBS, spent a significant portion of
The UCSF community grieves the loss of Betty Irene Moore, an advocate for patient safety and philanthropic leader, who passed away on Dec. 12, 2023, at age 95.
